Torrent Pharmaceuticals Ltd Financials
Company Logo

Torrent Pharmaceuticals Ltd Financial Statement

Torrent Pharmaceuticals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue2448.00
Operating Expense1589.00
Net Profit474.00
Net Profit Margin19.36
Earning Per Share14.00
EBIDTA871.00
Effective Tax Rate18.63

Torrent Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual8,532.90
Operating Expenses Annual5,643.60
Operating Profit Annual2,980.66
Interest Annual303.04
Depreciation223.52
Net Profit Annual1,357.08
Tax Annual559.49

Torrent Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning85.40
Cash Flow from Operations2,893.10
Cash Flow from Investing-296.07
Cash Flow from Financing-2,577.57
Cash Flow at the End104.86

Torrent Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)34.93
PBIT Margin (%)26.01
PBT Margin (%)25.92
Net PROFIT Margin (%)15.90
Return On Networth / Equity (%)20.43
Return On Networth /Employed (%)20.40
Return On Assets (%)12.41
Total Debt / Equity (X)0.60
Asset Turnover Ratio (%)0.78

Torrent Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual8,008.21
Total Current Assets Annual3,741.06
Non Current Assets Annual8,635.53
Total Shareholders Funds Annual6,828.76
Total Assets Annual12,376.59

Torrent Pharmaceuticals Ltd Earning Calls

EPS (INR)

Expected

14.71

Reported

14.71

Surprise

0.00%

Dec 2024

EPS beaten by 0.00%

Sep 2024

EPS beaten by 0.13%

Jun 2024

EPS beaten by -0.07%

FAQS on Torrent Pharmaceuticals Ltd Financials

As of May 24, 2025, Torrent Pharmaceuticals Ltd has a market capitalization of 1,09,468.65 Cr. Value Research classifies it as a Large-Cap company.

Yes, Torrent Pharmaceuticals Ltd is with a debt-to-equity ratio of 0.35.

In FY 2024 , Torrent Pharmaceuticals Ltd recorded a total revenue of approximately 9,485 Cr marking a significant milestone in the company's financial performance.

Torrent Pharmaceuticals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.4% and 0.1% annually, respectively..

Torrent Pharmaceuticals Ltd's current PE ratio is 57.98.

Torrent Pharmaceuticals Ltd's ROCE averaged 22.1% from the FY ending March 2023 to 2025, with a median of 21.8%. It peaked at 27.6% in March 2025, reflecting strong capital efficiency over the period..

Torrent Pharmaceuticals Ltd's latest EBIT is Rs. 2,823 Cr, surpassing the average EBIT of Rs. 2,306 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions